Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/687252


Drug Eluting Stents Market - Current Situation & Future Forecast


Description: The Market for Drug Eluting Coronary Stents grew by 3% in 2008 reaching $4.2 billion globally. Decline in average selling price was offset by growth in procedure volume and improved penetration levels.

The US market remained stable at $1.8 billion accounting for 43% of the world market. The launch of Medtronic’s Endeavor zotarolimus-eluting stent and Abbott’s & Boston Scientific’s Xience and Promus everolimus-eluting stents during the year, redistributed market shares with JnJ’s Cypher losing the most.

The Market for Drug Eluting Coronary Stents is exhibiting clear evidence of recovery with average annual PCI volumes rising by 5% in the US and 4% in Europe. Average penetration rates are also rising in all markets.

Drug Eluting Coronary Stents Market – Current Situation & Future Outlook is a New 2009 Edition of our best selling report. The report offers a timely analysis of the latest happenings with market revenue and growth rates for main regions, up-to-date market shares for leading companies and brands and market forecasts to 2015.

With Drug Eluting Coronary Stents Market – Current Situation & Future Outlook, you’ll be able to:

-Understand current market dynamics, competitors positions and market shares.
-Assess market size and growth potential for these combined drug devices.
-Monitor the competition’s marketed and in-development products.
-Identify emerging technologies and the companies behind them.
-Assess market potential and have access to forecasts till 2015.
-Leverage your own technology and brain storm new business opportunities.
-Investigate mergers, acquisitions and licensing possibilities

Drug Eluting Coronary Stents Market – Current Situation & Future Outlook is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this highly dynamic market.


Contents: 1. Executive Summary

2. Current Market Environment

2.1 Coronary Artery Disease (CAD)
2.2 Coronary Artery Bypass & Graft (CABG)
2.3 Percutaneous Coronary Intervention (PCI)
2.4 Late Stage Thrombosis Controversy
2.5 PCI Procedure Volumes
2.6 Penetration Rate Trends

3. Current Market Situation

3.1 Global Market for Drug Eluting Coronary Stents
3.2 US Market for Drug Eluting Coronary Stents
3.3 European Market for Drug Eluting Coronary Stents
3.4 Asia Pacific Market for Drug Eluting Coronary Stents

4. Competitive Environment

4.1 Leading Companies & Their Products
4.2 Leading Companies Market Shares
4.3 Competitive Situation

5. Future Outlook

5.1 Market Growth Trends
5.2 Market Forecast Scenarios
5.3 Drug Eluting Coronary Stents Consensus Forecast

6. Technology Update

6.1 Drug Eluting Stent Design
6.2 Surface Coating Technology
6.3 Drug Coated Stent Technology
6.4 Drug Eluting Stent Technology
6.5 Next Generation Drug Coated Stents
6.6 Bioresorbable Stents
6.7 Drug Eluting Balloons

7. Profiles of Main Companies

7.1 Abbott Vascular
7.2 Allvivo Vascular
7.3 ART (Arterial Remodeling Technologies)
7.4 Biocompatibles
7.5 Biosensors International
7.6 Biotronik
7.7 Blue Medical
7.8 Boston Scientific
7.9 Cook Medical
7.10 Cordis - Johnson & Johnson
7.11 Devax
7.12 Endovasc
7.13 Goodman
7.14 InnoCore
7.15 Medtronic
7.16 MIV Therapeutics
7.17 Reva Medical
7.18 Stentys
7.19 SurModics
7.20 Terumo
7.21 Translumina
7.22 X-Cell Medical
7.23 Xtent

List of Tables & Figures

1. Global Drug Eluting Coronary Stents Market (2003 - 2008)
2. US Drug Eluting Coronary Stents Market (2003 - 2008)
3. European Drug Eluting Coronary Stents Market (2003 - 2008)
4. Asia-Pacific Drug Eluting Stents Market (2003 - 2008)
5. Leading DES Brands Market Share (2008 - Global)
6. Leading DES Brands Market Share (2008 - US)
7. Leading DES Brands Market Share (2008 - Europe)
8. Leading DES Brands Market Share (2008 - Asia-Pacific)
9. PCI Procedure Volume Trends
10 DES Penetration Ratios
11 Leading Companies & Their Products
12. List of Potential Pharmacological Agents
13. Products in Development and Near Commercialization
14. Main Companies Market Shares
15. Leading Companies Competitive Share Momentum Grid
16 Linear Scenario Forecasts (2009 – 2015)
17. Drug Eluting Coronary Stents Market Forecast (2009 - 2015)


Companies Mentioned -Abbott Vascular -Allvivo Vascular -ART (Arterial Remodeling Technologies) -Biocompatibles -Biosensors International -Biotronik -Blue Medical -Boston Scientific -Cook Medical -Cordis - Johnson & Johnson -Devax -Endovasc -Goodman -InnoCore -Medtronic -MIV Therapeutics -Reva Medical -Stentys -SurModics -Terumo -Translumina -X-Cell Medical -Xtent


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/687252

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 29/11/2009 19:17:07
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Drug Eluting Stents Market - Current Situation & Future Forecast
Web Address:
http://www.researchandmarkets.com/reports/687252
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,850.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 29/11/2009 19:17:07

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)